Oclacitinib (APOQUEL) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy - Gonzales, AJ; Bowman, JW; Fici, GJ; Zhang, M; Mann, DW; Mitton-Fry, M (J Vet Pharmacol Ther, 2014)